Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihiko Nishio is active.

Publication


Featured researches published by Yoshihiko Nishio.


Journal of Biological Chemistry | 2003

Protein-tyrosine Phosphatase 1B as New Activator for Hepatic Lipogenesis via Sterol Regulatory Element-binding Protein-1 Gene Expression

Shinya Shimizu; Satoshi Ugi; Hiroshi Maegawa; Katsuya Egawa; Yoshihiko Nishio; Takeshi Yoshizaki; Kun Shi; Yoshio Nagai; Katsutaro Morino; Ken-ichi Nemoto; Takaaki Nakamura; Atsunori Kashiwagi

Like hyperglycemia, postprandial (diet-induced) hypertriglyceridemia is thought to play crucial roles in the pathogenesis of insulin resistant/metabolic syndrome. Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcription factor to induce postprandial hypertriglyceridemia. We found that insulin-resistant rats fed a diet high in fructose showed an increased proteintyrosine phosphatase 1B (PTP1B) content with strong expression of SREBP-1 mRNA in the liver. To clarify the association of PTP1B with SREBP-1 gene expression, we overexpressed PTP1B in rat hepatocytes, which led to increased mRNA content and promoter activity of SREBP-1a and -1c, resulting in the increased mRNA expression of fatty-acid synthase, one of the SREBP-1-responsive lipogenic genes. Because PTP1B overexpression increased phosphatase 2A (PP2A) activity, we inhibited PP2A activity by expression of its selective inhibitor, SV40 small t antigen and found that this normalized the PTP1B-enhanced SREBP-1a and -1c mRNA expressions through activation of the Sp1 site. These results indicate that PTP1B may regulate gene expression of SREBP-1 via enhancement of PP2A activity, thus mediating hepatic lipogenesis and postprandial hypertriglyceridemia. We demonstrate here a unique serial activation of the PTP1B-PP2A axis as a novel mechanism for the regulation of gene expression in the biosynthesis of triglyceride.


Archive | 1999

Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance

Atsunori Kashiwagi; Kazuya Shinozaki; Yoshihiko Nishio; Tomio Okamura; Noboru Toda; Ryuichi Kikkawa


Archive | 1999

Remedes preventifs ou therapeutiques contre les maladies associees a une anomalie fonctionnelle vasculaire en relation avec la resistance a l'insuline

Atsunori Kashiwagi; Kazuya Shinozaki; Yoshihiko Nishio; Tomio Okamura; Noboru Toda; Ryuichi Kikkawa


Archive | 1999

Vorbeugung und Behandlung von Krankheiten in Zusammenhang zu vaskularen funktionellen Störungen in Verbindung mit Insulinresistenz Prevention and treatment of diseases related to vascular functional disorders associated with insulin resistance

Atsunori Kashiwagi; Ryuichi Kikkawa; Yoshihiko Nishio; Tomio Okamura; Kazuya Shinozaki; Noboru Toda


Archive | 1999

COMPOSICIONES O REMEDIOS PARA ENFERMEDADES EN RELACION CON UNA DISFUNCION VASCULAR ASOCIADA A LA RESISTENCIA A LA INSULINA.

Atsunori Kashiwagi; Ryuichi Kikkawa; Yoshihiko Nishio; Tomio Okamura; Kazuya Shinozaki; Noboru Toda


Archive | 1999

Vorbeugung und behandlung von krankheiten in zusammenhang zu vaskularen funktionellen stoerungen un verbindung mit insulinresistenz Prevent and treat disease in context to vascular dysfunctions un connection with insulin resistance

Atsunori Kashiwagi; Kazuya Shinozaki; Yoshihiko Nishio; Tomio Okamura; Noboru Toda; Ryuichi Kikkawa


Archive | 1999

Prevent and treat disease in context to vascular functional disorders un connection with insulin resistance

Atsunori Kashiwagi; Kazuya Shinozaki; Yoshihiko Nishio; Tomio Okamura; Noboru Toda; Ryuichi Kikkawa


Archive | 1999

Prevention and treatment of diseases related to vascular functional disorders associated with insulin resistance

Atsunori Kashiwagi; Ryuichi Kikkawa; Yoshihiko Nishio; Tomio Okamura; Kazuya Shinozaki; Noboru Toda


Archive | 1999

Preventive agents or drugs against diseases associated with vascular functional anomaly in relation to insulin resistance

Atsunori Kashiwagi; Kazuya Shinozaki; Yoshihiko Nishio; Tomio Okamura; Noboru Toda; Ryuichi Kikkawa


Archive | 1999

Compositions or remedies for diseases in connection with a vascular dysfunction associated with insulin resistance.

Atsunori Kashiwagi; Ryuichi Kikkawa; Yoshihiko Nishio; Tomio Okamura; Kazuya Shinozaki; Noboru Toda

Collaboration


Dive into the Yoshihiko Nishio's collaboration.

Top Co-Authors

Avatar

Kazuya Shinozaki

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomio Okamura

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoshi Ugi

University of California

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Maegawa

Shiga University of Medical Science

View shared research outputs
Researchain Logo
Decentralizing Knowledge